title: Sluggish cognitive tempo in survivors of pediatric brain tumors.
abstract: The presence of neurocognitive late effects in survivors of pediatric brain tumors is well established. However, there remains some debate about how best to conceptualize these deficits. Sluggish cognitive tempo (SCT) is a proposed conceptual framework that has been used to describe a subset of children with ADHD who exhibit a particular profile characterized by lethargy, day dreaming and staring, and poor organization. Previous work has suggested that survivors of leukemia exhibit a similar profile, but it has not yet been examined in survivors of pediatric brain tumors. A sample of 65 survivors of pediatric brain tumors, 25 survivors of leukemia and 50 community controls completed the Child Behavior Checklist, with four items used to measure SCT. Survivors completed additional measures of neurocognitive functioning. Survivors of brain tumors demonstrated significantly greater symptoms of SCT than survivors of leukemia or controls. SCT was associated with attention problems and working memory deficits and the presence of a VP-shunt. Results provided conditional support for the presence of SCT in survivors of brain tumors, with further research needed to determine the clinical utility of the framework.
authors: Department of Psychology and Neuroscience, Duke University, Durham, NC, USA. victoria.willard@stjude.org
authors: Victoria W
authors: VW
authors: Willard
authors: Kristina K
authors: KK
authors: Hardy
authors: Taryn M
authors: TM
authors: Allen
authors: Eugene I
authors: EI
authors: Hwang
authors: Sridharan
authors: S
authors: Gururangan
authors: Sarah A
authors: SA
authors: Hostetter
authors: Melanie J
authors: MJ
authors: Bonner
mesh_terms: D000293:Adolescent; D001932:Brain Neoplasms / Q000150:complications*; D057189:Checklist; D002648:Child; D002652:Child Behavior; D003072:Cognition Disorders / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D012189:Retrospective Studies; D017741:Survivors / Q000523:psychology; D014888:Wechsler Scales
references: J Atten Disord. 2017 Feb;21(3):240-246
references: 23269197
references: J Clin Child Adolesc Psychol. 2013;42(2):161-73
references: 23094604
references: J Clin Child Adolesc Psychol. 2002 Mar;31(1):123-9
references: 11845644
references: J Abnorm Child Psychol. 2001 Jun;29(3):207-13
references: 11411783
references: Palliat Med. 2009 Dec;23(8):731-8
references: 19648224
references: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):145-9
references: 17765380
references: Eur J Paediatr Neurol. 2010 Mar;14(2):106-15
references: 19931477
references: Psychiatry Res. 2009 Aug 15;168(3):234-7
references: 19439364
references: J Int Neuropsychol Soc. 2002 Jan;8(1):115-24
references: 11843068
references: Cancer. 2002 Apr 1;94(7):2090-106
references: 11932914
references: Cancer. 2004 Nov 1;101(9):2116-25
references: 15389475
references: Drugs. 2008;68(13):1803-39
references: 18729534
references: Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):837-43
references: 19117694
references: J Abnorm Child Psychol. 2014 Jan;42(1):7-19
references: 23325455
references: J Pediatr Psychol. 2007 Oct;32(9):1050-4
references: 17933846
references: Ment Retard Dev Disabil Res Rev. 2006;12(3):184-91
references: 17061287
references: J Pediatr. 2008 Mar;152(3):394-9
references: 18280848
references: J Clin Oncol. 2004 Dec 1;22(23):4795-803
references: 15570081
references: J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1041-1050
references: 17667482
references: Brain Inj. 2005 Sep;19(10):777-85
references: 16175838
references: J Abnorm Child Psychol. 2010 Nov;38(8):1097-107
references: 20644992
references: Psychooncology. 2008 Nov;17(11):1157-61
references: 18636431
references: J Abnorm Child Psychol. 2004 Oct;32(5):491-503
references: 15500029
references: Psychooncology. 2013 Sep;22(9):1979-86
references: 23447439
references: Brain. 2000 May;123 ( Pt 5):1041-50
references: 10775548
references: Psychol Assess. 2009 Sep;21(3):380-9
references: 19719349
references: J Natl Cancer Inst. 2012 Sep 19;104(18):1386-95
references: 22927505
references: Childs Nerv Syst. 2012 Mar;28(3):399-404
references: 22080382
references: Pediatr Blood Cancer. 2010 Sep;55(3):525-31
references: 20658625
references: J Clin Oncol. 2004 Mar 15;22(6):999-1006
references: 15020603
references: J Clin Oncol. 2009 Aug 1;27(22):3691-7
references: 19581535
references: Pediatr Blood Cancer. 2011 Jul 15;57(1):110-8
references: 21337681
references: Sleep Med. 2003 Nov;4(6):579-82
references: 14607353
references: Psychooncology. 2005 May;14(5):386-95
references: 15386759
references: J Abnorm Child Psychol. 2010 Feb;38(2):173-84
references: 19731006
references: Neuropsychology. 2009 Nov;23(6):705-17
references: 19899829
references: J Neurooncol. 2005 May;72(3):245-53
references: 15937648
references: J Abnorm Child Psychol. 2012 Nov;40(8):1327-37
references: 22566025
references: Eur J Cancer. 2006 Nov;42(16):2765-72
references: 16935489
references: Child Neuropsychol. 2010;16(4):350-65
references: 20574866
references: Child Neuropsychol. 2001 Dec;7(4):265-72
references: 16210215